Michael J Hunter

This inventor holds 17 USPTO granted patents and 3 published patent applications and 6 EPO patents, primarily in Biotechnology. Top assignees: Janssen Pharmaceutica Nv, Janssen Biotech, Inc., Centocor Ortho Biotech Inc.. Active years: 2003-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael J Hunter. Retrieved from https://idiyas.com/inventor/michael-j-hunter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 3)

% Patents Active = 70.6

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 39(Granted Patents)

Location History:

Tioga, TX (US) (2003)
San Diego, CA (US) (2013 - 2019)
Santee, PA (US) (2019)
Santee, CA (US) (2019 - 2023)

Company Filing History:

9 out of 2,101

Janssen Pharmaceutica Nv

patents

4 out of 436

Janssen Biotech, Inc.

patents

2 out of 31

Centocor Ortho Biotech Inc.

patents

4. 1 out of 64

Janssen Sciences Ireland Unlimited Company

patents

5. 1 out of 834,601

Other

patents

Years Active: 2003-2024

Loading Chart...

Areas of Expertise:

Immunoglobulins

Antibody-Coupled Peptides

GDF15 Fusion Proteins

Neuropeptide Y Receptors

Huwentoxin-IV Variants

Binding Proteins

Plant Cysteine Proteases

Potato Virus A

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12134636 - Immunoglobulins and uses thereof (2024-11-05),

2. 11767354 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2023-09-26),

3. 11591379 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2023-02-28),

4. 11401315 - Immunoglobulins and uses thereof (2022-08-02),

5. 11208464 - GDF15 fusion proteins and uses thereof (2021-12-28),

6. 10968265 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2021-04-06),

7. 10858413 - Immunoglobulins and uses thereof (2020-12-08),

8. 10787495 - Immunoglobulins and uses thereof (2020-09-29),

9. 10640544 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2020-05-05),

10. 10428134 - Immunoglobulins and uses thereof (2019-10-01),

11. 10414808 - Huwentoxin-IV variants and methods of use (2019-09-17),

12. 10336812 - GDF15 fusion proteins and uses thereof (2019-07-02),

13. 9102751 - Huwentoxin-IV variants and methods of use (2015-08-11),

14. 9062120 - Binding proteins having tethered light chains (2015-06-23),

15. 8759067 - Polynucleotides encoding engineered plant cysteine proteases and their uses (2014-06-24),

Title: The Inventor Profile of Michael J Hunter

Introduction: Michael J Hunter is a prolific inventor based in Santee, California. With a passion for innovation and problem-solving, he has made significant contributions to various fields through his inventive spirit.

Latest Patents: Michael J Hunter holds several patents in the areas of technology and consumer products, showcasing his diverse range of interests and expertise.

Career Highlights: Throughout his career, Michael J Hunter has demonstrated a keen ability to identify gaps in the market and develop unique solutions to address them. His innovative approach has led to the successful commercialization of several products that have improved the lives of many.

Collaborations: Michael J Hunter has collaborated with industry leaders, research institutions, and fellow inventors to bring his ideas to life. These collaborations have not only enhanced the quality of his inventions but have also opened up new avenues for future innovations.

Conclusion: Michael J Hunter's dedication to innovation and his relentless pursuit of excellence make him a standout figure in the world of inventors. His contributions have had a lasting impact on various industries, and his inventive spirit continues to inspire others to push the boundaries of what is possible.

Profile summary based on public USPTO records.